As a co-founder of Synkrino, I built a biotech company that leverages artificial intelligence to discover and develop novel therapeutics for patients not responding to today's therapies. I have over 20 years of experience in applying computational methods to biological problems and generating insights from complex data sets, with a PhD in Bioinformatics (Machine Learning) and training in Molecular Evolution.My core competencies include Machine Learning, Real World Data (RWD), Pharmaceuticals, and IP development, which enable me to oversee the strategic direction, scientific vision, and operational excellence of Synkrino Biotherapeutics. I am also the inventor of a patent on AI analysis of RNA transcriptome for drug discovery, which has multiple use cases and potential applications in the biotech industry. My mission is to harness the power of AI and biotechnology to create innovative solutions that improve human health and well-being.